These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 25024596)
1. Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment. Leite NC; Villela-Nogueira CA; Cardoso CR; Salles GF World J Gastroenterol; 2014 Jul; 20(26):8377-92. PubMed ID: 25024596 [TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? Firneisz G World J Gastroenterol; 2014 Jul; 20(27):9072-89. PubMed ID: 25083080 [TBL] [Abstract][Full Text] [Related]
3. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. Lee BW; Lee YH; Park CY; Rhee EJ; Lee WY; Kim NH; Choi KM; Park KG; Choi YK; Cha BS; Lee DH; Diabetes Metab J; 2020 Jun; 44(3):382-401. PubMed ID: 32431115 [TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
5. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block. Athyros VG; Polyzos SA; Kountouras J; Katsiki N; Anagnostis P; Doumas M; Mantzoros CS Curr Vasc Pharmacol; 2020; 18(2):172-181. PubMed ID: 30961499 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558 [TBL] [Abstract][Full Text] [Related]
7. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. Younossi ZM; Golabi P; de Avila L; Paik JM; Srishord M; Fukui N; Qiu Y; Burns L; Afendy A; Nader F J Hepatol; 2019 Oct; 71(4):793-801. PubMed ID: 31279902 [TBL] [Abstract][Full Text] [Related]
8. Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD. Bazick J; Donithan M; Neuschwander-Tetri BA; Kleiner D; Brunt EM; Wilson L; Doo E; Lavine J; Tonascia J; Loomba R Diabetes Care; 2015 Jul; 38(7):1347-55. PubMed ID: 25887357 [TBL] [Abstract][Full Text] [Related]
9. NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms? Villela-Nogueira CA; Leite NC; Cardoso CR; Salles GF Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104526 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. Makri E; Goulas A; Polyzos SA Arch Med Res; 2021 Jan; 52(1):25-37. PubMed ID: 33334622 [TBL] [Abstract][Full Text] [Related]